DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Arthur M. Pappas Elected as Biotechnology Center Board Chairman
News | 10. 28. 2009
Arthur M. Pappas, MBA, founder and managing partner of the Research Triangle Park venture capital firm Pappas Ventures, has been elected chairman of the North Carolina Biotechnology Center's Board of Directors.
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.